This handout provides an overview of the Prescription Drug User Fee Act (PDUFA), its role in supporting FDA review capacity, and key priorities impacting the rare disease community during the upcoming reauthorization process.
New Name, Same Commitment to Rare Diseases
The EveryLife Foundation for Rare Diseases has become The RARE Foundation! Read more about our new brand and how it unifies our advocacy work on behalf of the rare disease community.
